Groups Feed

Metabolic syndrome refers to a cluster of risk factors — including obesity, insulin resistance, hypertension, and dyslipidemia — that increase the risk of diabetes and cardiovascular diseases. The market encompasses pharmaceuticals, diagnostics, and lifestyle management solutions targeting these interconnected conditions.

Market Overview

The metabolic syndrome market is growing as global obesity and sedentary lifestyles rise. Urbanization, poor diet, and genetic predispositions contribute to increasing cases, especially in middle-aged and older populations.

Market Drivers

Rising prevalence of diabetes and obesity: Major global health challenges driving treatment demand.

Welcome to the group! You can connect with other members, get updates and share photos.